Science Current Events | Science News | Brightsurf.com
 

HIV Virus Current Events | HIV Virus News | 4

Sort By: Page Views | Date
Infertility clinics are biased against patients with HIV
Infertility clinics are biased against patients infected with HIV, finds a study in this week's BMJ.   view more (2001-11-28)

Hopkins study suggests commercially available antibiotic may help fight dementia in HIV patients
An antibiotic commonly used to treat a variety of serious infections may also help prevent dementia in HIV patients, according to a test-tube study of human brain cells by Johns Hopkins University School of Medicine neurologist Jeffrey Rumbaugh, M.D., Ph.D.   view more (2006-04-06)

HIV persists in the gut despite long-term HIV therapy
Even with effective anti-HIV therapies, doctors still have not been able to eradicate the virus from infected individuals who are receiving such treatments, largely because of the persistence of HIV in hideouts known as viral reservoirs.   view more (2008-02-14)

New protein target may advance design of HIV and cancer drugs
Using small molecules containing platinum, Virginia Commonwealth University Massey Cancer Center researchers have created a process to inhibit a class of proteins important in HIV and cancer.   view more (2006-05-31)

Uncovering the Achilles' heel of the HIV-1 envelope
New structural details illustrate how a promising class of antibodies may block human immunodeficiency virus (HIV)-1 infection and reveal valuable clues for design of an effective HIV-1 vaccine.   view more (2008-01-14)

FEMALE GENITAL SHEDDING OF HIV-1 POSES INFECTION RISK (pp 1564, 1593)
A study in this week's issue of THE LANCET suggests that heterosexual women with HIV-1-including those who have had successful antiretroviral therapy-are at risk of transmitting HIV to their sexual partners and newborn infants as a result of viral shedding in the genital tract. Plasma HIV-1 RNA... view more (2001-11-07)

HIV's impact in Zimbabwe explored in new research
The impact of HIV in Zimbabwe since the early 1980s is explored in new research published this week in the journal PNAS.   view more (2007-08-28)

Researchers seek to solve mystery of natural HIV control
An international, multi-institutional research consortium is seeking to discover how a few HIV-infected individuals are naturally able to suppress replication of the virus.   view more (2006-08-17)

Harmless virus may hold key to more effective HIV drug discovery
A simple, harmless virus might hold the key to the more effective and efficient development of HIV and anti-viral drugs, UCI chemical biologists have found.   view more (2005-08-29)

NIAID scientists identify new cellular receptor for HIV
A cellular protein that helps guide immune cells to the gut has been newly identified as a target of HIV when the virus begins its assault on the body's immune system, according to researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of... view more (2008-02-11)

New study suggests potential for a broadly-protective HIV vaccine
New research conducted at the Uniformed Services University of the Health Sciences (USU) suggests that it may be possible to develop a vaccine that protects against the myriad strains of the HIV virus.   view more (2007-05-30)

Novel method to create personalized immunotherapy treatments
Argos Therapeutics and Université de Montréal today announced the presentation of new information on Argos'process for developing dendritic cell-based immunotherapies for HIV.   view more (2008-08-06)

Pediatric HIV: Oral lesions are commonly associated with the disease
Across the globe, the presence of HIV is wide-spread. At the end of 2004, the United Nations HIV/AIDS program estimated that 2.5 million children under the age of 15 were affected worldwide.   view more (2006-10-09)

Mutation protects from HIV - and increases risk of hepatitis C
More than 40 million people worldwide are infected with the human immunodeficiency virus HIV. In Africa alone this incurable immune deficiency caused more than two million deaths last year. Yet some people are resistant to infection: the reason for this is a mutation in their DNA which prevents the... view more (2002-07-17)

Engineered killer T cell recognizes HIV-1's lethal molecular disguises
Researchers at the University of Pennsylvania School of Medicine and colleagues in the United Kingdom have engineered T cells able to recognize HIV-1 strains that have evaded the immune system.   view more (2008-11-10)

'Good bacteria' in women give clues for slowing HIV transmission
Beneficial bacteria found in healthy women help to reduce the amount of vaginal HIV among HIV-infected women and make it more difficult for the virus to spread, boosting the possibility that "good bacteria" might someday be tapped in the fight against HIV.   view more (2008-02-07)

Quality not quantity important for immune response to HIV
When it comes to an immune response against HIV, research funded by the Wellcome Trust in the UK and the National Institutes of Health in the US has found that bigger is not necessarily better, contrary to conventional medical wisdom.   view more (2006-12-18)

Personalized immunotherapy to fight HIV/AIDS
For a long time, the main obstacle to creating an AIDS vaccine has been the high genetic variability of the HIV virus. Dr. Jean-Pierre Routy and his team from the Research Institute of the McGill University Health Centre (MUHC), in collaboration with Dr. Rafick Sékaly from the... view more (2008-08-18)

Failed HIV Drug Gets Second Chance with Addition of Gold Nanoparticles
Researchers at North Carolina State University have discovered that adding tiny bits of gold to a failed HIV drug rekindle the drug's ability to stop the virus from invading the body's immune system.   view more (2008-05-27)

Study finds limited options for backup HIV treatment in some developing countries
Thai researchers have discovered that patients who fail treatment with a commonly used, inexpensive, first-line antiretroviral therapy (ART) are also usually resistant to other, similar drugs, leaving progressively fewer options for replacement therapies.   view more (2007-01-09)

Study finds limited options for backup HIV treatment in some developing countries
Thai researchers have discovered that patients who fail treatment with a commonly used, inexpensive, first-line antiretroviral therapy (ART) are also usually resistant to other, similar drugs, leaving progressively fewer options for replacement therapies.   view more (2007-01-09)

HIV research project scoops innovation prize
Research that could lead to a breakthrough in the treatment of HIV has scooped a University of Manchester scientist a prestigious industry award.   view more (2004-11-23)

Scientists unlock more secrets of HIV and SARS
UK scientists have cracked one of the key biological processes used by viruses such as HIV and SARS when they replicate.   view more (2006-05-11)

Can the tonsils influence oral HIV transmission?
Current research demonstrates that the tonsils may possess the necessary factors to act as a transmission site for the spread of HIV.   view more (2007-07-26)

Viral recombination another way HIV fools the immune system
When individuals infected with HIV become infected with a second strain of the virus, the two viral strains can exchange genetic information, creating a third, recombinant strain of the virus. It is known that the presence of multiple viral strains, called superinfection, frequently leads to a loss... view more (2008-07-22)

Sort By: Page Views | Date
© 2008 BrightSurf.com